INPP4B protects from metabolic syndrome and associated disorders

Area of Science:

• Metabolic research
• Cancer biology
• Molecular signaling

Background:

• High-fat diets and obesity are linked to metabolic dysfunction and cancer.
• Cellular signals driving these conditions are complex and not fully understood.

Purpose of the Study:

• To investigate the role of Inositol Polyphosphate-4-Phosphatase Type II B (INPP4B) signaling in diet-induced metabolic dysfunction and cancer.
• To elucidate the molecular mechanisms by which INPP4B influences metabolic pathways and disease development.

Main Methods:

• Utilized a mouse model with Inositol Polyphosphate-4-Phosphatase Type II B (INPP4B) gene deletion (Inpp4b-/-).
• Administered a high-fat diet to assess metabolic parameters, insulin sensitivity, and disease progression.
• Analyzed key signaling pathways including AKT, PKC, SREBP1, and PPARG.

Main Results:

• INPP4B signaling protected mice from diet-induced metabolic dysfunction by suppressing AKT and PKC signaling, improving insulin sensitivity.
• Loss of INPP4B led to SREBP1 activation, increased lipogenesis, obesity, and non-alcoholic fatty liver disease (NAFLD).
• Inpp4b-/- male mice exhibited reduced energy expenditure, increased adiposity, insulin resistance, type II diabetes, and prostate inflammation, progressing to prostatic intraepithelial neoplasia (PIN).

Conclusions:

• INPP4B is crucial for maintaining metabolic health and preventing obesity-related diseases.
• INPP4B acts as a tumor suppressor in the context of metabolic dysfunction, protecting against prostate neoplasms.
• Targeting INPP4B signaling may offer therapeutic strategies for metabolic syndrome and associated cancers.